2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk.
By F. Mach, C. Baigent, Alberico L. Catapano, K. Koskinas, M. Casula, Lina Badimon, M. J. Chapman, G. De Backer, V. Delgado, B. Ference and 86 more. Atherosclerosis, 2019
4,665 citations recorded by the source corpus.
Authors/Task Force Members: François Mach* (Chairperson) (Switzerland), Colin Baigent* (Chairperson) (United Kingdom), Alberico L. Catapano* (Chairperson) (Italy), Konstantinos C. Koskinas (Switzerland), Manuela Casula (Italy), Lina Badimon (Spain), M. John Chapman (France), Guy G. De Backer (Belgium), Victoria Delgado (Netherlands), Brian A. Ference (United Kingdom), Ian M. Graham (Ireland), Alison Halliday (United Kingdom), Ulf Landmesser (Germany), Borislava Mihaylova (United Kingdom), Terje R. Pedersen (Norway), Gabriele Riccardi (Italy), Dimitrios J. Richter (Greece), Marc S. Sabatine (United States of America), Marja-Riitta Taskinen (Finland), Lale Tokgozoglu (Turkey), Olov Wiklund (Sweden)
Subfields: Economics and Econometrics, Endocrinology, Diabetes and Metabolism, Surgery
View Paper: https://www.semanticscholar.org/paper/05e5a4032d1f663b44c97a4e2f904dc1df29c5f8
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Economics and Econometrics
In Endocrinology, Diabetes and Metabolism
- Børge G. Nordestgaard
- Jan Boren
- Marja-Riitta Taskinen
- M. Chapman
- Alberico L. Catapano
- L. Tokgözoğlu
- Bart Staels
- I. Graham
In Surgery
- Børge G. Nordestgaard
- Jan Boren
- M. Chapman
- Marja-Riitta Taskinen
- Alberico L. Catapano
- L. Tokgözoğlu
- Bart Staels
- S. Kersten
Citations in the corpus
- Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society (2021, background): “13,20 Non-fasting TG is equivalent, if not superior, to fasting TG in assessing potential ASCVD risk.”